A new review finds that next-generation BET-targeted therapies, including selective inhibitors and PROTACs, are addressing ...

Scientists at VCU Massey Comprehensive Cancer Center have developed an autophagy-targeting chimera that redirects cancer ...

As therapeutic antibodies become more complex, where is the field making real progress and which problems are proving hardest ...

A new review highlights how physical forces such as blood flow, breathing and tissue stiffness must be replicated alongside ...

A new review examines how advances in drug design, PROTAC degraders and combination therapies are reviving the clinical ...

A new review examines how advances in drug design, PROTAC degraders and combination therapies are reviving the clinical ...

Ovarian cancer has long proved difficult to treat. Could the answer lie within the disease itself? Discover how synthetic ...

Sanjeev Luther is President and CEO of Ernexa Therapeutics and a member of the Board of Directors. Sanjeev is a seasoned ...

Preclinical findings from Genespire and SR-TIGET suggest a single administration of a liver-directed lentiviral gene therapy ...

Stanford University researchers have demonstrated that stem cell-derived vascular organoids can regenerate damaged ...

Scientists at the University of Southern California have engineered synthetic organiser cells that produce localised Wnt ...

A repurposed small molecule originally developed for spinal cord injury has demonstrated the ability to address multiple ...